Congenital Disorders of Glycosylation
Gene: COG3
Classified as LIMITED by ClinGen Congenital Disorders of Glycosylation GCEP on 19/09/2024 -https://search.clinicalgenome.org/CCID:008379
Variants reported in two families but only one underwent biochemical analysis. The mechanism of disease is unclear and assumed loss of function.Created: 12 Nov 2024, 1:15 a.m. | Last Modified: 12 Nov 2024, 1:15 a.m.
Panel Version: 1.54
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
congenital disorder of glycosylation MONDO:0015286
Publications
Mode of pathogenicity
Other
Two COG3 homozygous missense variants in four individuals from two unrelated consanguineous families. Clinical phenotypes of affected individuals include global developmental delay, severe intellectual disability, microcephaly, epilepsy, facial dysmorphism, and variable neurological findings.
Sources: LiteratureCreated: 21 Oct 2023, 1:49 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Congenital disorder of glycosylation, type IIbb, MIM# 620546
Publications
Gene: cog3 has been classified as Amber List (Moderate Evidence).
Gene: cog3 has been classified as Amber List (Moderate Evidence).
gene: COG3 was added gene: COG3 was added to Congenital Disorders of Glycosylation. Sources: Literature Mode of inheritance for gene: COG3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: COG3 were set to 37711075 Phenotypes for gene: COG3 were set to Congenital disorder of glycosylation, type IIbb, MIM# 620546 Review for gene: COG3 was set to AMBER